排石顆粒配合鹽酸坦洛新對(duì)輸尿管軟鏡治療大于2.0cm腎結(jié)石的療效分析
發(fā)布時(shí)間:2018-08-04 08:24
【摘要】:目的:探討排石顆粒配合鹽酸坦洛新對(duì)電子輸尿管軟鏡治療大于2cm腎結(jié)石的臨床療效。方法:將2015年03月-2017年03月江蘇大學(xué)附屬醫(yī)院90例應(yīng)用輸尿管軟鏡治療直徑大于2cm的腎石病患者按隨機(jī)分配的方法分為實(shí)驗(yàn)組和對(duì)照組,每組各45例。實(shí)驗(yàn)組配合中藥排石顆粒及鹽酸坦洛新緩釋片,對(duì)照組僅配合鹽酸坦洛新。服藥后每周復(fù)查一次,療程四周或至排石干凈。分別于第2周、第4周進(jìn)行療效判定。其觀察指標(biāo)為結(jié)石清除率、腎絞痛發(fā)生概率、結(jié)石的排凈時(shí)間以及膀胱過度活動(dòng)癥(OABSS)評(píng)分。結(jié)果:1.實(shí)驗(yàn)組結(jié)石清除率為97.8%,而對(duì)照組的清除率為86.7%,差異具有統(tǒng)計(jì)學(xué)意義(P0.05);2.治療組結(jié)石排凈天數(shù)為(5.6±1.67)天,對(duì)照組結(jié)石排凈天數(shù)為(12.7±2.63)天,差異具備統(tǒng)計(jì)學(xué)意義(P0.05);3.實(shí)驗(yàn)組術(shù)后發(fā)生腎絞痛概率為8.9%,而對(duì)照組術(shù)后發(fā)生腎絞痛概率為24.4%,差異具備統(tǒng)計(jì)學(xué)意義(P0.05);4.實(shí)驗(yàn)組OABSS評(píng)分為(5.3±1.19),對(duì)照組OABSS評(píng)分為(11.2±2.67),差異具有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論:排石顆粒配合鹽酸坦洛新對(duì)電子輸尿管軟鏡治療大于2.0cm結(jié)石患者具有結(jié)石清除率高、腎絞痛發(fā)生概率小、結(jié)石排出時(shí)間短以及并發(fā)癥少的治療優(yōu)勢。
[Abstract]:Objective: to investigate the clinical effect of Paishi granule combined with Tanluoxin Hydrochloride in the treatment of renal calculi larger than 2cm by electronic ureteroscopy. Methods: from March 2015 to March 2017, 90 patients with nephrolithiasis whose diameter was larger than 2cm were divided into experimental group (n = 45) and control group (n = 45). The experimental group combined with Paishi granules and Tanluoxin Hydrochloride sustained release tablets, while the control group only combined with Tanluoxin Hydrochloride. Recheck once a week after taking the medicine, the course of treatment or until the stone clean. The curative effect was evaluated at week 2 and week 4 respectively. The parameters were stone clearance rate, probability of occurrence of renal colic, time of stone removal and (OABSS) score of bladder hyperactivity. The result is 1: 1. The stone clearance rate of the experimental group was 97.8, while that of the control group was 86.7. The difference was statistically significant (P0.05). The days of stone drainage were (5.6 鹵1.67) days in the treatment group and (12.7 鹵2.63) days in the control group. The difference was statistically significant (P0.05). The probability of renal colic in the experimental group was 8.9 and that in the control group was 24.40.The difference was statistically significant (P0.05). The OABSS score was (5.3 鹵1.19) in the experimental group and (11.2 鹵2.67) in the control group (P0.05). Conclusion: Paishi granule combined with Tanluoxin Hydrochloride has the advantages of high removal rate of calculi, low probability of occurrence of renal colic, short time of stone excretion and fewer complications in patients with soft endoscopy of electronic ureter than in patients with 2.0cm calculi.
【學(xué)位授予單位】:江蘇大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R699.2
本文編號(hào):2163230
[Abstract]:Objective: to investigate the clinical effect of Paishi granule combined with Tanluoxin Hydrochloride in the treatment of renal calculi larger than 2cm by electronic ureteroscopy. Methods: from March 2015 to March 2017, 90 patients with nephrolithiasis whose diameter was larger than 2cm were divided into experimental group (n = 45) and control group (n = 45). The experimental group combined with Paishi granules and Tanluoxin Hydrochloride sustained release tablets, while the control group only combined with Tanluoxin Hydrochloride. Recheck once a week after taking the medicine, the course of treatment or until the stone clean. The curative effect was evaluated at week 2 and week 4 respectively. The parameters were stone clearance rate, probability of occurrence of renal colic, time of stone removal and (OABSS) score of bladder hyperactivity. The result is 1: 1. The stone clearance rate of the experimental group was 97.8, while that of the control group was 86.7. The difference was statistically significant (P0.05). The days of stone drainage were (5.6 鹵1.67) days in the treatment group and (12.7 鹵2.63) days in the control group. The difference was statistically significant (P0.05). The probability of renal colic in the experimental group was 8.9 and that in the control group was 24.40.The difference was statistically significant (P0.05). The OABSS score was (5.3 鹵1.19) in the experimental group and (11.2 鹵2.67) in the control group (P0.05). Conclusion: Paishi granule combined with Tanluoxin Hydrochloride has the advantages of high removal rate of calculi, low probability of occurrence of renal colic, short time of stone excretion and fewer complications in patients with soft endoscopy of electronic ureter than in patients with 2.0cm calculi.
【學(xué)位授予單位】:江蘇大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R699.2
【參考文獻(xiàn)】
相關(guān)期刊論文 前3條
1 李建偉;王芳;蔡芳震;高宏志;;分期輸尿管軟鏡鈥激光碎石術(shù)與微通道經(jīng)皮腎鏡碎石術(shù)治療2~4cm腎結(jié)石的隨機(jī)對(duì)照臨床研究[J];南方醫(yī)科大學(xué)學(xué)報(bào);2016年12期
2 郝宗耀;;經(jīng)皮腎鏡技術(shù)的教學(xué)方法探討[J];安徽醫(yī)藥;2013年08期
3 陳銳;;排石顆粒臨床應(yīng)用解析[J];中國社區(qū)醫(yī)師;2012年30期
相關(guān)碩士學(xué)位論文 前1條
1 宋小芬;868例泌尿系結(jié)石紅外光譜分析與臨床調(diào)查[D];南昌大學(xué)醫(yī)學(xué)院;2013年
,本文編號(hào):2163230
本文鏈接:http://sikaile.net/shoufeilunwen/mpalunwen/2163230.html
最近更新
教材專著